Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), issued a statement on January 18, 2026, regarding the recent passage and enactment of New Jersey legislation S.4894/A.6166 focused on vaccine coverage.
In her statement, Buteas said: “The passage and enactment of this important legislation is a win for New Jersey patients who need access to the life-saving vaccines that life sciences companies work so hard to research, discover and manufacture. A patient’s ability to access a medicine, medical device, vaccine, diagnostic tool or medical technology is critical to maintaining individual, family and societal health and wellness, and this bill expands patient access. We commend Governor Phil Murphy and the sponsors, Senators Joe Vitale and Andrew Zwicker, and Assemblywoman Carol Murphy, for their steadfast support of New Jersey’s patient community.”
The new law aims to improve access to vaccines for residents in New Jersey by ensuring broader coverage through legislative action.
